Glucagon-Like Peptide 1/Glucagon Receptor Dual Agonism Reverses Obesity in Mice
AUTOR(ES)
Pocai, Alessandro
FONTE
American Diabetes Association
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=2750209Documentos Relacionados
- Glucagon-like peptide-1 is a physiological incretin in rat.
- Glucagon-like peptide 1 improved glycemic control in type 1 diabetes
- Hepatic and glucagon-like peptide-1–mediated reversal of diabetes by glucagon receptor antisense oligonucleotide inhibitors
- Glucagon-like peptide 1 promotes satiety and suppresses energy intake in humans.
- The Extrapancreatic Effects of Glucagon-Like Peptide-1 and Related Peptides